Concerns Rise as Indian Pharma Stocks Plummet Amid US Tariff Fears

<h2>Pharma Stocks Take a Hit<&sol;h2>&NewLine;<p>Indian pharmaceutical stocks have experienced a significant downturn&comma; falling for the third consecutive session&period; This decline comes in response to mounting concerns surrounding potential US tariffs on pharmaceutical imports&period; The Nifty Pharma index dropped by 1&period;5&percnt;&comma; indicating a widespread impact across the sector&period;<&sol;p>&NewLine;<h2>Notable Declines in Key Players<&sol;h2>&NewLine;<p>Among the hardest hit were notable companies like Sun Pharma and Granules India&comma; with stocks tumbling up to 6&percnt;&period; Investors are reacting to the uncertain landscape as speculation around US tariffs grows&period; Such tariffs could potentially inflate the cost of medicines for American consumers and disrupt drug supplies&period;<&sol;p>&NewLine;<h2>Market Sentiment and Future Outlook<&sol;h2>&NewLine;<p>The mood among investors is increasingly cautious as they await further developments regarding US trade policies&period; This uncertainty is leading to reassessments of the profitability and market positions of key players in the Indian pharmaceutical industry&period; Industry analysts suggest that unless clarity is provided on these tariffs&comma; the pressure on pharma stocks is likely to continue&period;<&sol;p>&NewLine;